These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16303307)

  • 1. Chemotactic peptides: fMLF-OMe analogues incorporating proline-methionine chimeras as N-terminal residue.
    Mollica A; Paradisi MP; Varani K; Spisani S; Lucente G
    Bioorg Med Chem; 2006 Apr; 14(7):2253-65. PubMed ID: 16303307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel chemotactic For-Met-Leu-Phe-OMe (fMLF-OMe) analogues based on met residue replacement by 4-amino-proline scaffold: synthesis and bioactivity.
    Torino D; Mollica A; Pinnen F; Feliciani F; Spisani S; Lucente G
    Bioorg Med Chem; 2009 Jan; 17(1):251-9. PubMed ID: 19081258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid alpha/beta3-peptides with proteinogenic side chains. Monosubstituted analogues of the chemotactic tripeptide For-Met-Leu-Phe-OMe.
    Giordano C; Lucente G; Mollica A; Nalli M; Pagani Zecchini G; Paglialunga Paradisi M; Gavuzzo E; Mazza F; Spisani S
    J Pept Sci; 2004 Aug; 10(8):510-23. PubMed ID: 15347138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and bioactivity of chemotactic tetrapeptides: fMLF-OMe analogues incorporating spacer aminoacids at the lateral positions.
    Lucente G; Giordano C; Sansone A; Torino D; Spisani S
    Amino Acids; 2009 Jul; 37(2):285-95. PubMed ID: 18636221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotactic tripeptides incorporating at position 2 alpha-aminoacid residues with unsaturated side chains.
    Lucente G; Paradisi MP; Giordano C; Sansone A; Torino D; Spisani S
    Amino Acids; 2008 Aug; 35(2):329-38. PubMed ID: 18163179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, conformation, and biological activity of two fMLP-OMe analogues containing the new 2-[2'-(methylthio)ethyl]methionine residue.
    Torrini I; Paglialunga Paradisi M; Pagani Zecchini G; Lucente G; Gavuzzo E; Mazza F; Pochetti G; Traniello S; Spisani S
    Biopolymers; 1997 Oct; 42(4):415-26. PubMed ID: 9283291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of new active For-Met-Leu-Phe-OMe analogues containing para-substituted Phe residues.
    Mollica A; Feliciani F; Stefanucci A; Costante R; Lucente G; Pinnen F; Notaristefano D; Spisani S
    J Pept Sci; 2012 Jun; 18(6):418-26. PubMed ID: 22528501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hybrid alpha/beta-peptides: for-Met-Leu-Phe-OMe analogues containing geminally disubstituted beta2,2- and beta 3,3-amino acids at the central position.
    Mollica A; Paglialunga Paradisi M; Torino D; Spisani S; Lucente G
    Amino Acids; 2006 Jun; 30(4):453-9. PubMed ID: 16547648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified chemotactic peptides: synthesis, crystal conformation, and activity of For-Hse(Me)-Leu-Phe-OMe.
    Torrini I; Pagani Zecchini G; Paglialunga Paradisi M; Lucente G; Gavuzzo E; Mazza F; Pochetti G; Traniello S; Spisani S
    Biopolymers; 1994 Jan; 34(1):1-9. PubMed ID: 8110962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoro-modified chemotactic peptides: fMLF analogues.
    Koksch B; Dahl C; Radics G; Vocks A; Arnold K; Arnhold J; Sieler J; Burger K
    J Pept Sci; 2004 Feb; 10(2):67-81. PubMed ID: 14994985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isopeptide bonds in chemotactic tripeptides. Synthesis and activity of lysine-containing fMLF analogs.
    Pagani Zecchini G; Nalli M; Mollica A; Lucente G; Paglialunga Paradisi M; Spisani S
    J Pept Res; 2002 Jun; 59(6):283-91. PubMed ID: 12010519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of the peptide bond at position 2 in HCO-Met-Leu-Phe-OMe analogues as shown by studies on human neutrophils.
    Cavicchioni G; Breveglieri A; Boggian M; Vertuani G; Reali E; Spisani S
    J Pept Sci; 1996; 2(3):135-40. PubMed ID: 9231322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, biological activity and conformational studies of geometrically restricted tripeptide analogues of the chemoattractant HCO-Met-Leu-Phe-OMe.
    Boggian M; Vertuani G; Cavicchioni G; Pecoraro R; Scatturin A; Spisani S
    Farmaco; 1997; 52(6-7):439-44. PubMed ID: 9372595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, conformation and biological activity of centrally modified pseudopeptidic analogues of For-Met-Leu-Phe-OMe.
    Giordano C; Lucente G; Masi A; Paglialunga Paradisi M; Sansone A; Spisani S
    Amino Acids; 2007 Sep; 33(3):477-87. PubMed ID: 17021652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformationally constrained formyl methionyl tripeptides: structure-function study of analogs containing alpha,beta-dehydrophenylalanine and dehydroleucine.
    Bharadwaj A; Singh M; Bhandary K; Becker EL; Chauhan VS
    Pept Res; 1993; 6(6):298-307. PubMed ID: 8292847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New chemotactic dimeric peptides show high affinity and potency at the human formylpeptide receptor.
    Spisani S; Fraulini A; Varani K; Falzarano S; Cavicchioni G
    Eur J Pharmacol; 2007 Jul; 567(1-2):171-6. PubMed ID: 17481605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-peptido sulfonamides: for-Met-Leu-Phe-OMe analogues containing taurine and chiral beta-amino-ethanesulfonic acid residues.
    Giordano C; Nalli M; Paradisi MP; Sansone A; Lucente G; Spisani S
    Farmaco; 2004 Dec; 59(12):953-63. PubMed ID: 15598430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformations of heterochiral and homochiral proline-pseudoproline segments in peptides: context dependent cis-trans peptide bond isomerization.
    ; Raghothama S; Raghavender US; Aravinda S; Shamala N; Balaram P
    Biopolymers; 2009; 92(5):405-16. PubMed ID: 19373926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic formyl tripeptide chemoattractants: a C(alpha,alpha)-dialkylated, amphiphilic glycyl residue at position 1.
    Witkowska R; Zabrocki J; Spisani S; Falzarano MS; Toniolo C; Formaggio F
    J Pept Sci; 2003 Jun; 9(6):354-60. PubMed ID: 12846481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified chemotactic peptides: synthesis and biological activity of HCO-Met-delta ZLeu-delta ZPhe-OMe.
    Pagani Zecchini G; Torrini I; Paglialunga Paradisi M; Lucente G; Spisani S
    Farmaco; 1994 Nov; 40(11):739-42. PubMed ID: 7832975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.